Optimized human cell products for research
and drug discovery

Technology Founders

Nicolas Hannan PhD

Scientific Founder Nicholas R.F Hannan is currently a senior research associate at the Anne McLaren Laboratory for Regenerative Medicine, University of Cambridge funded by the LivES European liver consortium. He has worked in the human stem cell field for 10 years and has extensive expertise in stem cell pluripotency, developmental patterning specifically towards endoderm and the differentiation of stem cells using defined, xeno-free culture conditions. Prior to joining the University of Cambridge Nicholas completed his PhD at Monash University in the Australian Stem Cell Centre in Melbourne Australia. He has published research articles in high-impact journals in the fields of pancreatic and liver hepatocyte cell differentiation in defined conditions, identification of human foregut stem cells and the modelling of inherited metabolic liver disease and their subsequent genetic correction. This ground-breaking work has contributed to the development of the OptiDIFF platform for the production of iPSC- derived liver and pancreatic cells. Nicholas’s current research interests include the generation of endoderm-derived cell types including hindgut intestinal epithelium, hepatocytes, cholangiocytes, pancreatic cells and lung epithelium.

Candy Cho PhD

Scientific Founder Candy Hsin-Hua, Cho is currently a research associate at the Anne McLaren Laboratory for Regenerative Medicine, University of Cambridge funded by the Medical Research Council. She was awarded a PhD degree in differentiation of pluripotent stem cells into pancreatic islet cells at University of Cambridge, which was funded by MRC, Cambridge University Overseas Trust and Ministry of Education in Taiwan. She has worked in the human stem cell field for over 8 years, has extensive expertise in stem cell pluripotency, developmental patterning specifically towards endoderm and the differentiation of stem cells using defined, xeno-free culture conditions. Prior to joining the University of Cambridge Candy completed her B.Sc. in Biochemistry at University of Bristol, U.K. She has published research articles in high-impact journals in the fields of pancreatic and liver cell differentiation in defined conditions. This ground-breaking work has contributed to the development of the OptiDIFF platform for the production of iPSC-derived liver and pancreatic cells. Candy’s current research interests include the generation of pancreatic progenitor cells and its maturation into functional glucose responsive pancreatic islet cells.